Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.7B | 4.8B | 4.6B | 4.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.8B | 1.7B | 1.7B | 1.7B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.5B | 1.5B | 1.5B | 1.5B |
| Tax provision | 300M | 315M | 336M | 357M |
| Net income | 1.2B | 1.2B | 1.2B | 1.2B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.2B | 1.2B | 1.2B | 1.2B |
| Minority interests | -2M | -2M | -7M | -2M |
| Preferred stock dividends | — | — | — | — |